Pharmacokinetic Modeling of Ceftiofur Sodium Using Non-linear Mixed-Effects in Healthy Beagle Dogs

Ceftiofur (CEF) sodium is a third-generation broad-spectrum cephalosporin commonly used in an extra-label manner in dogs for the treatment of respiratory and urinary system infections. To contribute to the literature supporting CEF use in companion animals, we have developed a compartmental, non-lin...

Full description

Bibliographic Details
Main Authors: Jianzhong Wang, Benjamin K. Schneider, Jiao Xue, Pan Sun, Jicheng Qiu, Jonathan P. Mochel, Xingyuan Cao
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-10-01
Series:Frontiers in Veterinary Science
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fvets.2019.00363/full
_version_ 1828896109261488128
author Jianzhong Wang
Jianzhong Wang
Jianzhong Wang
Benjamin K. Schneider
Jiao Xue
Jiao Xue
Pan Sun
Pan Sun
Jicheng Qiu
Jicheng Qiu
Jonathan P. Mochel
Xingyuan Cao
Xingyuan Cao
Xingyuan Cao
author_facet Jianzhong Wang
Jianzhong Wang
Jianzhong Wang
Benjamin K. Schneider
Jiao Xue
Jiao Xue
Pan Sun
Pan Sun
Jicheng Qiu
Jicheng Qiu
Jonathan P. Mochel
Xingyuan Cao
Xingyuan Cao
Xingyuan Cao
author_sort Jianzhong Wang
collection DOAJ
description Ceftiofur (CEF) sodium is a third-generation broad-spectrum cephalosporin commonly used in an extra-label manner in dogs for the treatment of respiratory and urinary system infections. To contribute to the literature supporting CEF use in companion animals, we have developed a compartmental, non-linear mixed-effects (NLME) model of CEF pharmacokinetics in dogs (PK). We then used the mathematical model to predict (via Monte Carlo simulation) the duration of time for which plasma concentrations of CEF and its pharmacologically active metabolites remained above minimum inhibitory concentrations (respiratory tract Escherichia coli spp.). Twelve healthy beagle dogs were administered either 2.2 mg/kg ceftiofur-sodium (CEF-Na) intravenously (I.V) or 2.2 mg/kg CEF-Na subcutaneously (S.C). Plasma samples were collected over a period of 72 h post-administration. To produce a measurement of total CEF, both CEF and CEF metabolites were derivatized into desfuroylceftiofur acetamide (DCA) before analysis by UPLC-MS/MS. No adverse effects were reported after I.V or S.C dosing. The NLME PK models were parameterized using the stochastic approximation expectation maximization algorithm as implemented in Monolix 2018R2. A two-compartment mamillary model with first-order elimination and first-order S.C absorption best described the available kinetic data. Final parameter estimates indicate that CEF has a low systemic clearance (0.25 L/h/kg) associated with a low global extraction ratio E = 0.02) and a moderate volume of distribution (2.97 L/kg) in dogs. The absolute bioavailability after S.C administration was high (93.7%). Gender was determined to be a significant covariate in explaining the variability of S.C absorption. Our simulations predicted that a dose of 2.2 mg/kg CEF-Na S.C would produce median plasma concentrations of CEF of at least 0.5 μg/mL (MIC50) for ~30 h.
first_indexed 2024-12-13T14:37:52Z
format Article
id doaj.art-a2c1d0ca9c4e42bcbeb11728f5dffb51
institution Directory Open Access Journal
issn 2297-1769
language English
last_indexed 2024-12-13T14:37:52Z
publishDate 2019-10-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Veterinary Science
spelling doaj.art-a2c1d0ca9c4e42bcbeb11728f5dffb512022-12-21T23:41:41ZengFrontiers Media S.A.Frontiers in Veterinary Science2297-17692019-10-01610.3389/fvets.2019.00363488309Pharmacokinetic Modeling of Ceftiofur Sodium Using Non-linear Mixed-Effects in Healthy Beagle DogsJianzhong Wang0Jianzhong Wang1Jianzhong Wang2Benjamin K. Schneider3Jiao Xue4Jiao Xue5Pan Sun6Pan Sun7Jicheng Qiu8Jicheng Qiu9Jonathan P. Mochel10Xingyuan Cao11Xingyuan Cao12Xingyuan Cao13Department of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, China Agricultural University, Beijing, ChinaLaboratory of Quality & Safety Risk Assessment for Animal Products on Chemical Hazards (Beijing), Ministry of Agriculture and Rural Affairs, Beijing, ChinaBiomedical Sciences, SMART Pharmacology, College of Veterinary Medicine, Iowa State University, Ames, IA, United StatesBiomedical Sciences, SMART Pharmacology, College of Veterinary Medicine, Iowa State University, Ames, IA, United StatesDepartment of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, China Agricultural University, Beijing, ChinaLaboratory of Quality & Safety Risk Assessment for Animal Products on Chemical Hazards (Beijing), Ministry of Agriculture and Rural Affairs, Beijing, ChinaDepartment of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, China Agricultural University, Beijing, ChinaLaboratory of Quality & Safety Risk Assessment for Animal Products on Chemical Hazards (Beijing), Ministry of Agriculture and Rural Affairs, Beijing, ChinaDepartment of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, China Agricultural University, Beijing, ChinaLaboratory of Quality & Safety Risk Assessment for Animal Products on Chemical Hazards (Beijing), Ministry of Agriculture and Rural Affairs, Beijing, ChinaBiomedical Sciences, SMART Pharmacology, College of Veterinary Medicine, Iowa State University, Ames, IA, United StatesDepartment of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, China Agricultural University, Beijing, ChinaLaboratory of Quality & Safety Risk Assessment for Animal Products on Chemical Hazards (Beijing), Ministry of Agriculture and Rural Affairs, Beijing, ChinaLaboratory of Detection for Veterinary Drug Residues and Illegal Additives, Ministry of Agriculture and Rural Affairs, Beijing, ChinaCeftiofur (CEF) sodium is a third-generation broad-spectrum cephalosporin commonly used in an extra-label manner in dogs for the treatment of respiratory and urinary system infections. To contribute to the literature supporting CEF use in companion animals, we have developed a compartmental, non-linear mixed-effects (NLME) model of CEF pharmacokinetics in dogs (PK). We then used the mathematical model to predict (via Monte Carlo simulation) the duration of time for which plasma concentrations of CEF and its pharmacologically active metabolites remained above minimum inhibitory concentrations (respiratory tract Escherichia coli spp.). Twelve healthy beagle dogs were administered either 2.2 mg/kg ceftiofur-sodium (CEF-Na) intravenously (I.V) or 2.2 mg/kg CEF-Na subcutaneously (S.C). Plasma samples were collected over a period of 72 h post-administration. To produce a measurement of total CEF, both CEF and CEF metabolites were derivatized into desfuroylceftiofur acetamide (DCA) before analysis by UPLC-MS/MS. No adverse effects were reported after I.V or S.C dosing. The NLME PK models were parameterized using the stochastic approximation expectation maximization algorithm as implemented in Monolix 2018R2. A two-compartment mamillary model with first-order elimination and first-order S.C absorption best described the available kinetic data. Final parameter estimates indicate that CEF has a low systemic clearance (0.25 L/h/kg) associated with a low global extraction ratio E = 0.02) and a moderate volume of distribution (2.97 L/kg) in dogs. The absolute bioavailability after S.C administration was high (93.7%). Gender was determined to be a significant covariate in explaining the variability of S.C absorption. Our simulations predicted that a dose of 2.2 mg/kg CEF-Na S.C would produce median plasma concentrations of CEF of at least 0.5 μg/mL (MIC50) for ~30 h.https://www.frontiersin.org/article/10.3389/fvets.2019.00363/fullceftiofur sodiumpharmacokineticsNLMEmonte carlo simulationsdogs
spellingShingle Jianzhong Wang
Jianzhong Wang
Jianzhong Wang
Benjamin K. Schneider
Jiao Xue
Jiao Xue
Pan Sun
Pan Sun
Jicheng Qiu
Jicheng Qiu
Jonathan P. Mochel
Xingyuan Cao
Xingyuan Cao
Xingyuan Cao
Pharmacokinetic Modeling of Ceftiofur Sodium Using Non-linear Mixed-Effects in Healthy Beagle Dogs
Frontiers in Veterinary Science
ceftiofur sodium
pharmacokinetics
NLME
monte carlo simulations
dogs
title Pharmacokinetic Modeling of Ceftiofur Sodium Using Non-linear Mixed-Effects in Healthy Beagle Dogs
title_full Pharmacokinetic Modeling of Ceftiofur Sodium Using Non-linear Mixed-Effects in Healthy Beagle Dogs
title_fullStr Pharmacokinetic Modeling of Ceftiofur Sodium Using Non-linear Mixed-Effects in Healthy Beagle Dogs
title_full_unstemmed Pharmacokinetic Modeling of Ceftiofur Sodium Using Non-linear Mixed-Effects in Healthy Beagle Dogs
title_short Pharmacokinetic Modeling of Ceftiofur Sodium Using Non-linear Mixed-Effects in Healthy Beagle Dogs
title_sort pharmacokinetic modeling of ceftiofur sodium using non linear mixed effects in healthy beagle dogs
topic ceftiofur sodium
pharmacokinetics
NLME
monte carlo simulations
dogs
url https://www.frontiersin.org/article/10.3389/fvets.2019.00363/full
work_keys_str_mv AT jianzhongwang pharmacokineticmodelingofceftiofursodiumusingnonlinearmixedeffectsinhealthybeagledogs
AT jianzhongwang pharmacokineticmodelingofceftiofursodiumusingnonlinearmixedeffectsinhealthybeagledogs
AT jianzhongwang pharmacokineticmodelingofceftiofursodiumusingnonlinearmixedeffectsinhealthybeagledogs
AT benjaminkschneider pharmacokineticmodelingofceftiofursodiumusingnonlinearmixedeffectsinhealthybeagledogs
AT jiaoxue pharmacokineticmodelingofceftiofursodiumusingnonlinearmixedeffectsinhealthybeagledogs
AT jiaoxue pharmacokineticmodelingofceftiofursodiumusingnonlinearmixedeffectsinhealthybeagledogs
AT pansun pharmacokineticmodelingofceftiofursodiumusingnonlinearmixedeffectsinhealthybeagledogs
AT pansun pharmacokineticmodelingofceftiofursodiumusingnonlinearmixedeffectsinhealthybeagledogs
AT jichengqiu pharmacokineticmodelingofceftiofursodiumusingnonlinearmixedeffectsinhealthybeagledogs
AT jichengqiu pharmacokineticmodelingofceftiofursodiumusingnonlinearmixedeffectsinhealthybeagledogs
AT jonathanpmochel pharmacokineticmodelingofceftiofursodiumusingnonlinearmixedeffectsinhealthybeagledogs
AT xingyuancao pharmacokineticmodelingofceftiofursodiumusingnonlinearmixedeffectsinhealthybeagledogs
AT xingyuancao pharmacokineticmodelingofceftiofursodiumusingnonlinearmixedeffectsinhealthybeagledogs
AT xingyuancao pharmacokineticmodelingofceftiofursodiumusingnonlinearmixedeffectsinhealthybeagledogs